SCHEMBL16218907

SCHEMBL16218907

CC(C)OP1(=O)OCCC(C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26944775 0.80 ALDH1A1 (0.32)
SCHEMBL18567596 0.79 ALDH1A1 (0.34)
SCHEMBL15833834 0.79 ALDH1A1 (0.34)
SCHEMBL13862874 0.79 ALDH1A1 (0.34)
SCHEMBL24667598 0.76
SCHEMBL26944836 0.76 ALDH1A1 (0.30)
SCHEMBL15557458 0.75
SCHEMBL16937877 0.74
SCHEMBL30736104 0.71
SCHEMBL4763204 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11744831-B2 Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (US) 2023-09-05 US disclosed
US-20170312283-A1 ANTIVIRAL JAK INHIBITORS USEFUL IN TREATING OR PREVENTING RETROVIRAL AND OTHER VIRAL INFECTIONS THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2017-11-02 US disclosed
US-9662332-B2 Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (US) 2017-05-30 US disclosed
US-20140328793-A1 ANTIVIRAL JAK INHIBITORS USEFUL IN TREATING OR PREVENTING RETROVIRAL AND OTHER VIRAL INFECTIONS EMORY UNIVERSITY (US) 2014-11-06 US disclosed